Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares OutstandingWages, Salaries and Other
Ratios

Capricor Therapeutics (CAPR) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Capricor Therapeutics (CAPR) over the last 17 years, with Q3 2025 value amounting to $45.7 million.

  • Capricor Therapeutics' Shares Outstanding rose 1335.05% to $45.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.7 million, marking a year-over-year increase of 1335.05%. This contributed to the annual value of $45.6 million for FY2024, which is 4633.95% up from last year.
  • According to the latest figures from Q3 2025, Capricor Therapeutics' Shares Outstanding is $45.7 million, which was up 1335.05% from $45.7 million recorded in Q2 2025.
  • Over the past 5 years, Capricor Therapeutics' Shares Outstanding peaked at $45.7 million during Q3 2025, and registered a low of $22.8 million during Q1 2021.
  • Its 5-year average for Shares Outstanding is $30.9 million, with a median of $25.8 million in 2023.
  • In the last 5 years, Capricor Therapeutics' Shares Outstanding surged by 14811.36% in 2021 and then soared by 229.21% in 2022.
  • Capricor Therapeutics' Shares Outstanding (Quarter) stood at $24.2 million in 2021, then increased by 4.37% to $25.2 million in 2022, then increased by 23.4% to $31.1 million in 2023, then skyrocketed by 46.34% to $45.6 million in 2024, then rose by 0.3% to $45.7 million in 2025.
  • Its Shares Outstanding was $45.7 million in Q3 2025, compared to $45.7 million in Q2 2025 and $45.7 million in Q1 2025.